Edition:
United States

Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.32USD
8 Dec 2016
Change (% chg)

$-0.04 (-2.94%)
Prev Close
$1.36
Open
$1.37
Day's High
$1.37
Day's Low
$1.32
Volume
5,067
Avg. Vol
147,066
52-wk High
$3.20
52-wk Low
$1.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- February 8 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 --
(2) OUTPERFORM 1 1 1 --
(3) HOLD 0 0 0 --
(4) UNDERPERFORM 0 0 0 --
(5) SELL 0 0 0 --
No Opinion 0 0 0 --
Mean Rating 2.00 2.00 2.00 --

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Feb-17 1 0.05 0.05 0.05 0.67
Year Ending Feb-18 1 0.06 0.06 0.06 0.73
Earnings (per share)
Year Ending Feb-17 1 -0.97 -0.97 -0.97 -1.40
Year Ending Feb-18 1 -1.02 -1.02 -1.02 -1.40

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Nov-14 0.01 0.03 0.02 163.64
Quarter Ending Aug-14 0.08 0.01 0.07 90.12
Quarter Ending May-14 0.20 0.06 0.15 72.55
Quarter Ending Feb-14 0.17 0.20 0.03 18.24
Earnings (per share)
Quarter Ending Nov-14 -0.30 0.30 0.60 -200.00
Quarter Ending Aug-14 -0.30 -0.30 0.00 -0.00
Quarter Ending May-14 -0.30 0.10 0.40 -133.33
Quarter Ending Feb-14 -0.30 -0.20 0.10 -33.33

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Feb-17 0.05 0.05 0.05 0.05 0.67
Year Ending Feb-18 0.06 0.06 0.06 0.06 0.73
Earnings (per share)
Year Ending Feb-17 -0.97 -0.97 -0.97 -0.97 -1.40
Year Ending Feb-18 -1.02 -1.02 -1.02 -1.02 -1.40

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Feb-17 0 0 0 0
Year Ending Feb-18 0 0 0 0
Earnings
Year Ending Feb-17 0 0 0 0
Year Ending Feb-18 0 0 0 0